arrow
H

Hisashi Yamada

Hyogo Medical University
H指数:41
被引数:6,290

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Clinical behavior toward outpatients with major depressive disorder based on guideline education for psychiatrists

基于精神科医生指南教育的对门诊重度抑郁症患者临床行为研究

2025-12-230
OAAI
Maintenance pharmacotherapy after electroconvulsive therapy in inpatients with major depressive disorder: 198 prescriptions in a real-world clinical setting

电休克治疗后住院重度抑郁症患者的维持期药物治疗:一项真实世界临床环境中的198例处方研究

2025-10-110
OAAI
The effect of education regarding treatment guidelines for schizophrenia and major depressive disorders on psychiatrists' hypnotic medication prescribing behavior: a multicenter study
2024-05-290
OAAI
Effect of education regarding treatment guidelines for schizophrenia and depression on the treatment behavior of psychiatrists: A multicenter study
2023-09-086
OA
Change of prescription for patients with schizophrenia or major depressive disorder during admission: real-world prescribing surveys from the effectiveness of guidelines for dissemination and education psychiatric treatment project
2023-06-283
OAAI
The characteristics of discharge prescriptions including pro re nata psychotropic medications for patients with schizophrenia and major depressive disorder from the survey of the Effectiveness of guidelines for dissemination and education in psychiatric treatment (EGUIDE) project
2022-12-263
OAAI
Effects of electroconvulsive therapy on the use of anxiolytics and sleep medications: a propensity score-matched analysis
2022-11-093
PRE
Characteristics of the treatments for each severity of major depressive disorder: A real-world multi-site study
2022-08-016
OAAI
Prescription of Anticholinergic Drugs in Patients With Schizophrenia: Analysis of Antipsychotic Prescription Patterns and Hospital Characteristics
2022-05-179
OAAI
A dissemination and education programme to improve the clinical behaviours of psychiatrists in accordance with treatment guidelines for schizophrenia and major depressive disorders: the Effectiveness of Guidelines for Dissemination and Education in Psychiatric Treatment (EGUIDE) project
2022-04-2112
OAAI
The characteristics of patients receiving psychotropic pro re nata medication at discharge for the treatment of schizophrenia and major depressive disorder: A nationwide survey from the EGUIDE project

出院时接受精神药物治疗精神分裂症和重度抑郁症的患者的特征: 来自egide项目的全国性调查

2022-03-0112
PRE
Hypnotic medication use among inpatients with schizophrenia and major depressive disorder: results of a nationwide study
2022-01-0117
OAAI
Characteristics of discharge prescriptions for patients with schizophrenia or major depressive disorder: Real-world evidence from the Effectiveness of Guidelines for Dissemination and Education (EGUIDE) psychiatric treatment project
2021-09-0129
OAAI